Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA

Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA

Abstract The FDA Amendments Act (FDAAA) required that information for certain clinical trials, such as details about study design features and endpoints, as well as results, be publicly reported in ClinicalTrials.gov . We conducted a cross-sectional analysis of phase III trials with primary results...

Full description

Bibliographic Details
Main Authors: Ramtin Talebi, Rita F. Redberg, Joseph S. Ross
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Trials
Subjects:
FDA Amendments Act
Clinical trial reporting
Result reporting
Accurate reporting
Online Access:http://link.springer.com/article/10.1186/s13063-020-04603-9

Internet

http://link.springer.com/article/10.1186/s13063-020-04603-9

Similar Items